New Releases from NCBI BookshelfTarlatamab (Imdelltra): Indication: The treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after at least 2 prior lines of therapy including platinum-based chemotherapy: Reimbursement Recommendation [Internet].​Tarlatamab (Imdelltra): Indication: The treatment of adult patients with extensive-stage small cell lung cancer with disease progression on or after at least 2 prior lines of therapy including platinum-based chemotherapy: Reimbursement Recommendation [Internet].